vTv Therapeutics (VTVT) Capital Expenditures (2014 - 2025)
vTv Therapeutics' (VTVT) quarterly Capital Expenditures came in at -$24000.0 in Q4 2025, up 22.58% year-over-year from -$19578.9 in Q4 2024, and up 29.41% quarter-over-quarter from -$34000.0 in Q3 2025.
Powered by 
Analysis
vTv Therapeutics (VTVT) Capital Expenditures (2014 - 2025) Analysis & Trends
vTv Therapeutics has disclosed Capital Expenditures across 7 years of filings, most recently posting -$24000.0 for Q4 2025.
- In Q4 2025, Capital Expenditures rose 22.58% year-over-year to -$24000.0; the TTM figure through Jun 2026 stood at -$58000.0 (up 54.69% YoY), while the FY2025 annual figure was -$125000.0, down 5.04% from the prior year.
- Capital Expenditures came in at -$24000.0 for Q4 2025 at vTv Therapeutics, up from -$34000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of -$24000.0 in Q4 2025 to a low of -$105000.0 in Q4 2023.
- Average Capital Expenditures over 3 years is -$38777.8, with a median of -$31000.0 recorded in 2024.
- Year-over-year, Capital Expenditures jumped 70.48% in 2024 and declined 17.86% in 2025.
- Over 3 years, Capital Expenditures stood at -$105000.0 in 2023, then surged by 70.48% to -$31000.0 in 2024, then climbed by 22.58% to -$24000.0 in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$24000.0 in Q4 2025, -$34000.0 in Q3 2025, and -$34000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 533.00 Mn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | 2.29 Mn |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn | 25.02 Mn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 12.41 Mn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -24,000.00 |
| Sep 30, 2025 | -34,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | -33,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -28,000.00 |
| Dec 31, 2023 | -105,000.00 |
| Dec 31, 2017 | 18,000.00 |
| Mar 31, 2017 | 39,000.00 |
| Dec 31, 2016 | -181,000.00 |
| Sep 30, 2016 | 7,000.00 |
| Jun 30, 2016 | -3,000.00 |
| Mar 31, 2016 | 264,000.00 |
| Dec 31, 2015 | -1.49 Mn |
| Sep 30, 2015 | -15,000.00 |
| Jun 30, 2015 | -2,000.00 |
| Mar 31, 2015 | 1.61 Mn |
| Dec 31, 2014 | -2,000.00 |